Researchers have developed a novel method using CRISPR to study transcription factors affecting blood cell development. The ...

Bully Ray calls this AEW star "green," but admits that they not only have the "it" factor, but should become a champion ...

Sarcomas are among the rarest and most enigmatic forms of cancer, accounting for just 1% of all adult cancer diagnoses ...

The detection of metastases in Merkel cell carcinoma (MCC) requires additional testing, such as pancytokeratin (panCK) or CK20, with no guarantee of success. Recent findings have identified ...

Transcription factor networks disproportionately enrich for heritability of blood cell phenotypesPublication: ...

Nurix stock gains as SNY expands its partnership, licensing a research program targeting a previously untreatable transcription factor for autoimmune diseases.

US clinical-stage biotech Nurix Therapeutics (Nasdaq: NRIX) announced that Sanofi (Euronext: SAN) has exclusively licensed an ...

CD8 T cells lacking Tet1/3 preferentially differentiate into short-lived effector and effector memory cells following acute ...

Sanofi has returned to Nurix Therapeutics for another autoimmune candidate, paying $15 million and committing up to $465 ...

Nurix Therapeutics has widened its collaboration with Sanofi, granting the French pharmaceutical company an exclusive license to an undisclosed program targeting a previously undruggable transcription ...